RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 109 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $868,000 | +56.1% | 96,800 | -6.5% | 0.00% | 0.0% |
Q2 2016 | $556,000 | +13.2% | 103,500 | -3.1% | 0.00% | 0.0% |
Q1 2016 | $491,000 | -16.6% | 106,800 | -5.7% | 0.00% | 0.0% |
Q4 2015 | $589,000 | -14.0% | 113,300 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $685,000 | -61.7% | 113,300 | 0.0% | 0.00% | -66.7% |
Q2 2015 | $1,789,000 | +66.7% | 113,300 | -4.1% | 0.00% | +200.0% |
Q1 2015 | $1,073,000 | 0.0% | 118,200 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,073,000 | -7.0% | 118,200 | -1.7% | 0.00% | -50.0% |
Q3 2014 | $1,154,000 | -11.8% | 120,300 | +6.2% | 0.00% | 0.0% |
Q2 2014 | $1,309,000 | +29.1% | 113,300 | 0.0% | 0.00% | +100.0% |
Q1 2014 | $1,014,000 | +62.5% | 113,300 | +148.5% | 0.00% | 0.0% |
Q4 2013 | $624,000 | -13.3% | 45,600 | -5.4% | 0.00% | 0.0% |
Q3 2013 | $720,000 | +183.5% | 48,200 | +77.6% | 0.00% | 0.0% |
Q2 2013 | $254,000 | – | 27,134 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 888,132 | $7,966,000 | 6.12% |
LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 1,054,678 | $9,460,000 | 3.30% |
Kassirer Asset Management Corp | 363,700 | $3,262,000 | 2.36% |
WATER ISLAND CAPITAL LLC | 3,359,140 | $30,131,000 | 1.91% |
Banco BTG Pactual S.A. | 338,889 | $3,040,000 | 1.43% |
GARDNER LEWIS ASSET MANAGEMENT L P | 1,941,012 | $17,411,000 | 1.41% |
FIRST NEW YORK SECURITIES LLC /NY | 237,500 | $2,130,375,000 | 1.41% |
ALPINE ASSOCIATES MANAGEMENT INC. | 3,804,600 | $34,089,000 | 1.25% |
Atika Capital Management LLC | 300,000 | $2,691,000 | 1.10% |
Atika Capital Management LLC | 298,200 | $2,672,000 | 1.09% |